Motixafortide - Biokine Therapeutics/BioLineRx
At a glance
- Drug Originator Kyoto University
- Drug Licenced by BioLineRx; Gamida-Cell; Guangzhou Gloria Biosciences; Hong Seng Technology
- Drug Class Antianaemics; Antineoplastics; Cyclic peptides; Peptides
- Mechanism of Action Apoptosis stimulants; CXCR4 receptor antagonists
- USA Patent Applicants BIOLINERX LTD
- NDAs 1
Table of Contents
Disclaimer